Oxidative Stress in Radiation-Induced Cardiotoxicity.
Zhang PingYang PengHong LangCai XinyongZeng ZhiyiWu XiaochengZeng HongLiang ShaoPublished in: Oxidative medicine and cellular longevity (2020)
There is a distinct increase in the risk of heart disease in people exposed to ionizing radiation (IR). Radiation-induced heart disease (RIHD) is one of the adverse side effects when people are exposed to ionizing radiation. IR may come from various forms, such as diagnostic imaging, radiotherapy for cancer treatment, nuclear disasters, and accidents. However, RIHD was mainly observed after radiotherapy for chest malignant tumors, especially left breast cancer. Radiation therapy (RT) has become one of the main ways to treat all kinds of cancer, which is used to reduce the recurrence of cancer and improve the survival rate of patients. The potential cause of radiation-induced cardiotoxicity is unclear, but it may be relevant to oxidative stress. Oxidative stress, an accumulation of reactive oxygen species (ROS), disrupts intracellular homeostasis through chemical modification and damages proteins, lipids, and DNA; therefore, it results in a series of related pathophysiological changes. The purpose of this review was to summarise the studies of oxidative stress in radiotherapy-induced cardiotoxicity and provide prevention and treatment methods to reduce cardiac damage.
Keyphrases
- radiation induced
- oxidative stress
- radiation therapy
- diabetic rats
- reactive oxygen species
- dna damage
- papillary thyroid
- ischemia reperfusion injury
- induced apoptosis
- end stage renal disease
- locally advanced
- pulmonary hypertension
- ejection fraction
- squamous cell
- chronic kidney disease
- high resolution
- emergency department
- newly diagnosed
- peritoneal dialysis
- cell death
- squamous cell carcinoma
- prognostic factors
- early stage
- heat shock
- childhood cancer
- endothelial cells
- young adults
- drug induced
- fatty acid
- electronic health record
- cell free